Log in

NASDAQ:NAIINatural Alternatives International Stock Price, Forecast & News

+0.04 (+0.55 %)
(As of 06/5/2020 04:00 PM ET)
Today's Range
Now: $7.25
50-Day Range
MA: $6.80
52-Week Range
Now: $7.25
Volume10,989 shs
Average Volume6,192 shs
Market Capitalization$49.23 million
P/E RatioN/A
Dividend YieldN/A
Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States and internationally. It operates through two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. The company offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. It also provides strategic partnering services, such as customized product formulation, clinical studies, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, packaging and delivery system design, and regulatory review. In addition, the company sells beta-alanine ingredient under the CarnoSyn and SR CarnoSyn names. It manufactures products in various forms, including capsules, tablets, chewable wafers, and powders. The company's private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores. Natural Alternatives International, Inc. was founded in 1980 and is headquartered in Carlsbad, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.57 out of 5 stars

Industry, Sector and Symbol

Industry Medicinals & botanicals
Current SymbolNASDAQ:NAII



Sales & Book Value

Annual Sales$138.29 million
Cash Flow$1.33 per share
Book Value$10.11 per share


Net Income$6.54 million


Market Cap$49.23 million
Next Earnings Date9/22/2020 (Estimated)
OptionableNot Optionable

Receive NAII News and Ratings via Email

Sign-up to receive the latest news and ratings for NAII and its competitors with MarketBeat's FREE daily newsletter.

Natural Alternatives International (NASDAQ:NAII) Frequently Asked Questions

How has Natural Alternatives International's stock been impacted by COVID-19 (Coronavirus)?

Natural Alternatives International's stock was trading at $6.60 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, NAII shares have increased by 9.8% and is now trading at $7.25. View which stocks have been most impacted by Coronavirus.

When is Natural Alternatives International's next earnings date?

Natural Alternatives International is scheduled to release its next quarterly earnings announcement on Tuesday, September 22nd 2020. View our earnings forecast for Natural Alternatives International.

How were Natural Alternatives International's earnings last quarter?

Natural Alternatives International, Inc. (NASDAQ:NAII) released its earnings results on Thursday, May, 14th. The company reported ($0.61) earnings per share for the quarter. The business earned $25.48 million during the quarter. Natural Alternatives International had a negative net margin of 3.19% and a negative return on equity of 4.84%. View Natural Alternatives International's earnings history.

Has Natural Alternatives International been receiving favorable news coverage?

News stories about NAII stock have been trending extremely negative recently, according to InfoTrie. The research group identifies negative and positive press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Natural Alternatives International earned a media sentiment score of -5.0 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the stock's share price in the next several days. View the latest news aboutNatural Alternatives International.

Are investors shorting Natural Alternatives International?

Natural Alternatives International saw a drop in short interest in the month of May. As of May 15th, there was short interest totaling 1,600 shares, a drop of 59.0% from the April 30th total of 3,900 shares. Based on an average daily volume of 8,200 shares, the short-interest ratio is presently 0.2 days. Approximately 0.0% of the shares of the stock are short sold. View Natural Alternatives International's Current Options Chain.

Who are some of Natural Alternatives International's key competitors?

What other stocks do shareholders of Natural Alternatives International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Natural Alternatives International investors own include Ascent Solar Technologies (ASTI), Aurora Cannabis (ACB), AbbVie (ABBV), LightPath Technologies (LPTH), Canadian Solar (CSIQ), Azure Power Global (AZRE), BJs Wholesale Club (BJ), BIOLINERX LTD/S (BLRX), Chromadex (CDXC) and CV Sciences (CVSI).

Who are Natural Alternatives International's key executives?

Natural Alternatives International's management team includes the following people:
  • Mr. Mark A. LeDoux, Chairman & CEO (Age 65)
  • Mr. Kenneth E. Wolf, Pres, COO, Sec. & Treasurer (Age 58)
  • Mr. Michael E. Fortin, Chief Financial Officer (Age 42)
  • Mr. Eugene M. Quast, VP of Global Sales (Age 60)

What is Natural Alternatives International's stock symbol?

Natural Alternatives International trades on the NASDAQ under the ticker symbol "NAII."

Who are Natural Alternatives International's major shareholders?

Natural Alternatives International's stock is owned by a number of institutional and retail investors. Top institutional investors include Wedbush Securities Inc. (2.57%), Morgan Stanley (1.83%), BlackRock Inc. (0.20%) and Integrated Wealth Concepts LLC (0.15%). View institutional ownership trends for Natural Alternatives International.

Which institutional investors are selling Natural Alternatives International stock?

NAII stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc.. View insider buying and selling activity for Natural Alternatives International.

Which institutional investors are buying Natural Alternatives International stock?

NAII stock was acquired by a variety of institutional investors in the last quarter, including Wedbush Securities Inc., Morgan Stanley, and Integrated Wealth Concepts LLC. View insider buying and selling activity for Natural Alternatives International.

How do I buy shares of Natural Alternatives International?

Shares of NAII can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Natural Alternatives International's stock price today?

One share of NAII stock can currently be purchased for approximately $7.25.

How big of a company is Natural Alternatives International?

Natural Alternatives International has a market capitalization of $49.23 million and generates $138.29 million in revenue each year. Natural Alternatives International employs 246 workers across the globe.

What is Natural Alternatives International's official website?

The official website for Natural Alternatives International is www.nai-online.com.

How can I contact Natural Alternatives International?

Natural Alternatives International's mailing address is 1535 Faraday Ave, Carlsbad CA, 92008. The company can be reached via phone at 760-736-7700 or via email at [email protected]

This page was last updated on 6/7/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.